Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.10 +3.28%
EPS Growth %: +115.4%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +115.4%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
- Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
